Logo

Takara Bio

Takara Bio USA Developing High-Throughput Multiplex Panels in Partnership With Clinical Labs
Premium

The laboratory-developed tests can be validated and customized by customers, which the firm says engenders increased flexibility.

Takara Bio USA, BioExcel Diagnostics Partner for Infectious Disease Panels

The firms will partner to offer a range of multiplex syndromic panels to detect infectious disease pathogens and antimicrobial resistance markers.

Takara Bio USA Wins European Patent Challenge Filed by Jumpcode Genomics Over NGS Library Prep

The patent, granted in 2019, is part of Takara's portfolio covering methods used in RNA-sequencing library prep kits containing ZapR technology.

Adaptive Biotechnologies, Takara Bio T Cell Receptor Sequencing Methods Rank High in Benchmarking Study
Premium

An international team of researchers put nine immune cell sequencing methods head to head, including RNA-based and DNA-based ones, using the same T-cell sample.

Takara Bio Forays Into Diagnostic Space With SmartChip COVID-19 Testing
Premium

The firm's SmartChip platform consists of a high-throughput liquid dispenser and a PCR instrument and can provide more than 5,000 reactions in one run.

Jun 8, 2020

Takara Bio, BioSyntagma Develop High-Throughput SARS-CoV-2 Detection Method

Apr 14, 2020

New Studies Compare, Set Benchmarks for Single-Cell RNA Sequencing Methods
Premium

Feb 20, 2020

Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics for Late-Stage Liver Disease

Jun 21, 2017

Takara, Formulatrix Develop Miniaturized Single-Cell Sequencing Workflows

Feb 15, 2017

WaferGen Expects 62 Percent Rise in Q4 Revenues

Jan 18, 2017

Takara Bio USA Holdings Completes Acquisition of Rubicon Genomics

Dec 15, 2016

Takara Bio USA to Acquire Rubicon Genomics

Dec 15, 2016

WaferGen Regains Compliance With Nasdaq Listing Requirements

Nov 28, 2016

WaferGen Enacts Reverse Stock Split

Nov 16, 2016

Wafergen Stockholders Approve Takara Bio Merger

Nov 8, 2016

WaferGen Q3 Revenues Up 20 Percent on SmartChip Sales

Nov 1, 2016

Takara Bio USA Inks RNA-seq Supply Deal With Allen Institute for Brain Science

Oct 31, 2016

WaferGen Releases Preliminary Q3 Results, Urges Stockholders to Vote for Takara Merger

Aug 9, 2016

WaferGen Q2 Revenues Jump 56 Percent as Takara Bio Takeover Looms

Jun 6, 2016

WaferGen Biosystems, Takara Bio Ink Distribution Deal in Japan

May 13, 2016

Takara Bio to Acquire WaferGen Biosystems

May 10, 2016

WaferGen Biosystems Q1 Revenues Up 68 Percent

Apr 26, 2016

Takara Bio, IDT Form RNA Sequencing Partnership

Mar 8, 2016

WaferGen Q4 Revenues Rise Sharply With Increased SmartChip Sales

Jan 28, 2016

WaferGen Expects to Report Sharp Increase in Q4 Revenues

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.